Cancer Cells Surface Proteins: New Immunotherapy Targets 2026
UCSF researchers found oncogenic protein Src on cancer cell surfaces, potentially creating new immunotherapy targets for hard-to-treat solid tumors.
By Priya Patel
2 articles tagged "immunotherapy"
UCSF researchers found oncogenic protein Src on cancer cell surfaces, potentially creating new immunotherapy targets for hard-to-treat solid tumors.
Phase 3 trial shows camrelizumab plus CAPOX with maintenance therapy significantly improves overall survival vs CAPOX alone in HER2-negative gastric cancer.